Cc:rate diagnosis of PID is difficult owing to the aac d of precision of the clinical features. Jacobson n Westrom 8 were the first to describe the use of ---------------------s~ndenceto: Dr G L Ridgway, Department of Clinical weibiology, University College Hospital, Grafton Way, London E6AU,UK the laparoscope to confirm a clinicaldiagnosis of PID and they demonstrated poor correlation between clinical and laparoscopic findings. The minimum criteria they required for a clinical diagnosis were acute abdominal pain, plus two or more of: abnormal vaginal discharge, fever, vomiting, menstrual irregularities, urinary symptoms, marked tenderness of the pelvic adnexae on bimanual examination, palpable adnexal mass or swelling, or an erythrocyte sedimentation rate~15 rom/h. Of 814 women satisfying these criteria, 532 (65%) had verifiable pathology on laparoscopy. Similar studies by a number of workers 9 -12 confirmed PID in 50-70% of women diagnosed on clinical criteria. Laparoscopy is therefore essential for the detection of pelvic patholo~, but even here the criteria described by Westrom for the visual diagnosis of PID-oedema, hyperaemia and tubal exudate, may be too rigid as they indicate quite a late stage in the disease.
Endosalpingitis may be present and cause substantial damage to the epithelial lining of the tube, without any apparent laparoscopic signs. The presence of~than 5 polymorphonuclear leucocytes per high power field in smears prepared from swabs taken from the fallopian tubes at the time of laparoscopy is indicative of endosalpingitis, irrespective of the outward appearance of the tubes.
The diagnosis of PIO causes great anxiety to the patient and to her partner, with regard to her future fertility, possibly her sexuality, and perhaps her partner's fidelity. Therefore, it is important to obtain an exact diagnosis, rather than to treat empirically on suspicion. Laparoscopy allows direct visualization of the tubes, and cultures via the fimbrial openings are readily obtained. These cultures are more likely to reflect the true microbial aetiology13,14. Laparoscopy for the diagnosis of PID is used routinely in the USA and Scandinavia but so far only selectively in the UK. It is important that clinicians appreciate the contribution that laparoscopy makes to the management of PIO.
The aetiology of PIO is polymicrobial. Most cases are sexually transmitted, but non-sexually transmitted organisms are thought to cause PIO in a previously compromised genital tract. The flora of the lower genital tract in women is a complex ecosystem of aerobic and anaerobic bacteria. Surgical procedures, pregnancy, parturition, phases of the menstrual cycle and the insertion of an intrauterine contraceptive device may all result in alteration of the flora. Aerobic organisms, eg Escherichia coli, streptococci, Haemophilus inf/uenzae, and anaerobic organisms, eg Peptoaxxus spp., Peptostreptocoa:us spp. and Bacteroides sPf" are found. Eschenbach et al. I4
and Sweet et az.t isolated aerobic and anaerobic organisms from 17% and 15% respectively of culde-sac specimens from women with PID.
Any antibiotic regimen selected for PID therapy must be effectiveagainst N. gonormoeae, C. trachomatis, M. hominis and the facultative aerobic and anaerobic bacteria associated with the disease. There is no single agent currently available with a spectrum reliably covering all these organisms. In the USA, the following regimens are recommended for hospitalized patientsl", Cefoxitin 2 g intravenously (iv) 6 hourly or cefotetan (not available in the UK) 2 g iv 12 hourly plus doxycycline 100mg 12 hourly iv or orally. An alternative regimen is gentamicin 2 mg/kg iv as a single dose, followed by a maintenance dose of 1.5 mg/kg 8 hourly, with clindamycin 900mg iv 8 hourly. These combinations are continued until 48 h after clinical improvement. Both groups should continue doxycycline (orally) for a total of 14 days. Cunningham and co-workers'? evaluated tetracycline or procaine penicillin or ampicillin for the treatment of acute PID. N. gonorrhoeae was isolated from 68% of the patients; tests for C. trachomatis were not performed. Somewhat surprisingly, both regimens were equally effective for gonococcal or non-gonococcal disease with respect to clinical cure. However, Heinonenl'' compared the efficacy of iv benzyl penicillin plus metronidazole with doxycycline plus metronidazole iv for 48 h followed by oral therapy. In the doxycycline group, clinical failures were reported in 19% of cases, compared to 53% clinical failures in the penicillin group. Of the patients with documented chlamydial infection in the penicillin group, 75% failed to respond to the therapy. This well conducted study demonstrated elegantly that treatment with penicillin and metronidazole is not appropriate in this condition.
Second and third generation cephalosporins, eg ceftizoxime or cefotaxime, although apparently effective in PID, only have limited data to support their use. Further, these agents have no activity against C. trachomatis or M. hominis and cannot therefore be used alone. Monson et az.t 9 evaluated cefotaxime in gonococcal and non-gonococcal PID. Sixteen of 24 patients admitted were evaluable. Three of these had N. gonorrhoeae isolated from the cervix as the only pathogen identified, and two had N. gonorrhoeae isolated from the cervix and Escherichia coli from the cul-de-sac. All five had an excellent response to the therapy, with complete resolution of signs and symptoms within 5 days. Seven of 11 women with non-gonococcal disease had complete response within 5 days of commencing treatment. However, two patients required additional oral doxycycline. Two patients, subsequently found to have a tubo-ovarian abscess, also failed to respond. Sweet et al. 20 noted the persistence of C. trachomatis in endometrial biopsies from 12 of 18 patients after treatment with cefoxitin.
A combination of ticarcillin and clavulanic acid for 5 days was compared with clindamycin and gentamicin both for 5 days by Appuzzio et aU I Twenty-three patients were given 3 g of ticarcillin plus 100mg of clavulanic acid, 4 hourly iv. Two patients (9%)failed to respond. Twenty-four patients received gentamicin, 3-5 mg/kglday intramuscularly (im) plus clindamycin, 600mg 6 hourly iv. All patients in this group were clinicallycured. Berkeley and Ledger22 reported on the efficacy of using imipenemlciIastatin(500 mg 6 hourly iv for a minimum of 4 days), in 55 patients with obstetric or gynaecological infections. Of 49 evaluable patients, 43 (88%) were clinically cured. Three out of 6 clinical failures required operative intervention for pelvic abscesses, implying inadequate cover for likely organisms with imipenem alone.
Macrolides show good in vitro activity against C. trachomatis 23 • Worm et aJ24 compared roxithromycin (300 mg daily for 7 days) with erythromycin (500mg 12 hourly for 7 days), in a double blind study. At follow up 2 weeks after completion of therapy, 97% (38 of 39) patients in the roxithromycin group, compared to 88% (37 of 42) in the erythromycin group were cured of C. trachomatis infection. Bacteriological cure rates 2 weeks after the end of treatment were therefore similar in both treatment groups. The usual dose of erythromycin (2 g daily) is associated with a high incidence of gastrointestinal side effects. Linneman and colleagues-? reported a randomized double blind study to determine whether 1 g of erythromycin daily would be as effective as the 2 g regimen. Seventy-six of the 114 patients were evaluable. Twelve (27%) of the 45 patients treated with 1 g still yielded positive cultures for C. trachomatis after treatment, compared to 3 (10%) of 31 patients treated with the 2 g dose. They concluded that the lower dose was inadequate therapy for chlamydia! PID. Furthermore, it should be noted that erythromycin is inactive against M. hominis.
Ciprofloxacin has been suggested as a promising new agent for treating acute PID. Heinonen-" compared ciprofloxacin 200mg 12 hourly, iv for 2 days, followed by 750mg orally for a total of 14 days with doxycycline 100mg 12 hourly, iv for 2 days and metronidazole -SOO mg 12 hourly, iv for 2 days, followed by combined oral therapy for a total of 14 days. The overall success rate was 94%(15of 16)with ciprofloxacin and 70% (14 of 20) with doxycyclinel metronidazole.
For patients not requiring hospitalization for PID the recommended USA regimen is cefoxitin (2 g im) plus probenecid, or any other equivalent cephalosporin as a single dose, plus doxycycline100mg twice daily for 14 daysl 6. Oral erythromycin may be substituted at a dose of 500mg 6 hourly, for 14 days, with the reservation concerning M. hominis noted above. . OrieI27 suggested that a suitable regimen for usẽ the UK could be cefotaxime 1 g 12 hourly iv or im for 24 h, followed by doxycycline 100 mg 12 ourly, orally (parenteral doxycycline is not available
In the UK), plus metronidazole 200 mg 8 hourly orally, for 14 days. An association between increased risk of PIO and multiple sexual partners has been previously noted 28 • Eschenbachl'' reported that 58% of the male partners of women with PIO and cervical ?n?rrhoea had gonococcal urethral infection. imilarly, of the partners of women with nongonococcal PIO, 13% had urethral gonorrhoea, and 13% non-gonococcalurethritis (NGV). Approximately half of all the male partners were asymptomatic. Thus, all sexual contacts must be examined for the presence of sexually transmissable organisms, and U'res.pective of the culture results, they should ecelve treatment with a regimen effective against oth N. gonorrhoeae and C. trachomatis.
With better antimicrobial therapy, the usefulness of surgery in the treatment of PID has decreased in recent years. Failure to respond to antibiotics, pelvic mas~es, persistence of pain and ruptured tubo-oV~an abscess are indications for surgical interyention 29 • During surgery, a conservative approach IS the rule, eg drainage procedures and unilateral adnexectomy rather than total abdominal hyster-ec~omf and bilateral salpingo-oophorectomy-''<S.
. ID 18 a Widespread sexually transmitted disease, WIth substantial economic and personal impact. Tõ e an impression on the incidence of this disease In the Community, and to avoid involuntary infertility and long term morbidity in young women, education (both of the profession and the general public), prOmpt and accurate diagnosis, and aggressive and ap~oPriatetherapy of both partners are mandatory. e are some way from achieving these goals. MUch more scientifically based research is required, encompasSing pathogenicity, diagnosis and treatment (eyall:I ated using both clinical and microbiological c~tena). For the present, laparoscopy is the 'gold bandard' diagnostic procedure, and appropriate hroa~spectrum antimicrobial therapy with early tl~SPlt~ation and parenteral therapy (if indicated) e mamstay of treatment.
